FLNA and prostate carcinoma: Immunoblotting results indicated that calpeptin (40 μM for 24 h) effectively inhibited calpain activity, and protected filamin A and androgen receptor from cleavage by calpain in human prostate cancer cell lines PC-3 (Liu et al. 2014).